Sanofi (SNYNF) Other Non-Current Assets (2009 - 2026)

Sanofi (SNYNF) posted Other Non-Current Assets of $743.4 million for Q1 2026, up 207.05% sequentially from $242.1 million in Q4 2025, and down 94.85% YoY from $14.4 billion in Q1 2025.

Sanofi (SNYNF) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Sanofi (SNYNF) has 18 years of Other Non-Current Assets data on file, last reported at $743.4 million in Q1 2026.

  • Quarterly Other Non-Current Assets fell 94.85% year-over-year to $743.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $743.4 million (down 94.85% YoY) and the FY2025 annual result came in at $242.1 million, down 93.96% from the prior year.
  • Other Non-Current Assets advanced to $743.4 million in Q1 2026 per SNYNF's latest filing, from $242.1 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $14.4 billion in Q1 2025, with the low at $161.3 million in Q3 2025.
  • Average Other Non-Current Assets over 5 years is $3.8 billion, with a median of $3.5 billion recorded in 2023.
  • Year-over-year, Other Non-Current Assets rose 29.59% in 2025 and sank 94.85% in 2026.
  • Sanofi's Other Non-Current Assets stood at $3.2 billion in 2022, then gained by 9.65% to $3.5 billion in 2023, then climbed by 15.83% to $4.0 billion in 2024, then tumbled by 93.96% to $242.1 million in 2025, then soared by 207.05% to $743.4 million in 2026.
  • Business Quant data shows SNYNF's Other Non-Current Assets at $743.4 million in Q1 2026, $242.1 million in Q4 2025, and $161.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.23 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 14.11 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 10.54 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 19.81 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 12.76 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 4.55 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 9.83 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 200.00 Mn
10 Sanofi - - 9.49 Bn 743.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 743.42 Mn
Dec 31, 2025 242.12 Mn
Sep 30, 2025 161.33 Mn
Jun 30, 2025 4.65 Bn
Mar 31, 2025 14.44 Bn
Dec 31, 2024 4.01 Bn
Jun 30, 2024 3.59 Bn
Dec 31, 2023 3.46 Bn
Jun 30, 2023 3.26 Bn
Dec 31, 2022 3.16 Bn
Jun 30, 2022 3.53 Bn
Dec 31, 2021 3.58 Bn
Jun 30, 2021 3.25 Bn
Dec 31, 2020 3.26 Bn
Jun 30, 2020 3.34 Bn
Dec 31, 2019 110,688.77
Jun 30, 2019 2.54 Bn
Dec 31, 2018 3.21 Bn
Sep 30, 2018 1.16 Mn
Jun 30, 2018 1.19 Mn